Duke University Hospital

Running trials

• Not yet recruiting

  Cilostazol for Prevention of Recurrent Stroke Trial

  NCT07174414· Phase 3· Source

• Recruiting

  PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis

  NCT07232069· Phase 3· Source

• Recruiting

  ANDREAS Registry (Assessment of Novel Drug-coated Balloon Revascularization: Effectiveness, Angiographic Outcomes, and Safety)

  NCT07559903· Source

• Not yet recruiting

  IMPACT-HTN Study of Patients With Hypertension

  NCT07579260· Source

• Recruiting

  Low Intensity Focused Ultrasound Stimulation in Stroke Patients - Parameter Optimization

  NCT07220005· Source

• Recruiting

  Photon-counting CT in Chest Imaging

  NCT07031336· Source

• Recruiting

  Repurposing Tilmanocept for Cardiac Sarcoidosis

  NCT07159074· Phase 2· Source

• Recruiting

  Telerehabilitation In The Home After Stroke

  NCT06682429· Source

• Recruiting

  A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  NCT06948318· Phase 3· Source

• Recruiting

  A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

  NCT06747351· Phase 3· Source

• Recruiting

  Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System

  NCT06080074· Phase 2· Source

• Recruiting

  Alleviant ALLAY-HFrEF Study

  NCT06812533· Source

• Recruiting

  A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  NCT06722235· Phase 3· Source

• Recruiting

  Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction

  NCT06736574· Phase 3· Source

• Recruiting

  A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)

  NCT06619561· Phase 2· Source

• Recruiting

  A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Mesial Temporal Lobe Epilepsy (MTLE)

  NCT06422923· Phase 1/2· Source

• Recruiting

  GERD in Children With Cystic Fibrosis

  NCT06617013· Source

• Recruiting

  BiVACOR® Total Artificial Heart Early Feasibility Study

  NCT06174103· Source

• Recruiting

  Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis- Magnetic Resonance Imaging

  NCT05907629· Source

• Recruiting

  Strategy for Improving Stroke Treatment Response

  NCT05948566· Phase 2· Source

• Recruiting

  A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events

  NCT06112418· Source

• Recruiting

  A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma

  NCT05651932· Phase 1· Source

• Recruiting

  Alleviant ALLAY-HF Study

  NCT05685303· Source

• Recruiting

  A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer

  NCT05253651· Phase 3· Source

• Recruiting

  PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes

  NCT05390892· Phase 4· Source

• Active, not recruiting

  Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis

  NCT05047172· Phase 3· Source

• Active, not recruiting

  SP Thoracic IDE Study

  NCT05150210· Source

• Recruiting

  Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future, Higher Yield Trials

  NCT05338697· Source

• Recruiting

  Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))

  NCT05135091· Phase 3· Source

• Recruiting

  A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer

  NCT04831580· Source

• Recruiting

  Femoral Peri-arterial Local Anesthetic Injection Via Peri-arterial Perineural Catheter Reverses Tourniquet Associated Ischemic Hypertension

  NCT04454203· Phase 4· Source

• Recruiting

  Physiologic Signals and Signatures With the Accuryn Monitoring System - The Accuryn Registry

  NCT04669548· Source

• Recruiting

  TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention

  NCT04294927· Source

• Recruiting

  Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

  NCT03907046· Phase 3· Source

• Active, not recruiting

  Treatment Free Remission After Combination Therapy With Ruxolitinib Plus Tyrosine Kinase Inhibitors

  NCT03610971· Phase 2· Source

• Active, not recruiting

  A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis

  NCT03165734· Phase 3· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Stroke7 recruiting
• Heart failure5 recruiting
• Coronary artery disease4 recruiting
• High blood pressure3 recruiting
• Epilepsy2 recruiting
• Immune thrombocytopenia (ITP)2 recruiting
• Type 2 diabetes2 recruiting
• Atrial fibrillation1 recruiting
• Cervical cancer1 recruiting
• Chronic kidney disease1 recruiting
• CIDP (chronic inflammatory demyelinating polyneuropathy)1 recruiting
• Colorectal cancer1 recruiting
• Congenital heart disease1 recruiting
• COPD1 recruiting
• Cystic fibrosis1 recruiting
• Multiple myeloma1 recruiting
• Ovarian cancer1 recruiting
• Sarcoidosis1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Terminated

  Guanfacine for Hyperactivity in Children With Down Syndrome (HYPEbeGONE_DS)

  NCT06042257· Phase 2· Source

• Completed

  Acute Coronary Syndrome KCMC

  NCT04563546· Source

• Withdrawn

  Partial Heart Transplantation

  NCT06055556· Source

• Terminated

  A Study of Intra-tumoral Administered MTX110 in Patients With Recurrent Glioblastoma

  NCT05324501· Phase 1· Source

• Completed

  Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve Decongestion Management System (DMS)

  NCT05174312· Source

• Terminated

  Oxbryta® Product Registry An Observational Study Designed to Evaluate the Effect of Oxbryta in Individuals With SCD

  NCT04930445· Source

• Completed

  Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures

  NCT05067634· Phase 3· Source

• Completed

  Safety and Efficacy of Allogeneic NK Cell Infusions in Patients With Relapsed/Refractory AML and High Risk MDS

  NCT04901416· Phase 1· Source

• Completed

  Pharmacokinetics Study of VALTOCO® in Pediatric Subjects With Epilepsy

  NCT05076838· Phase 1/2· Source

• Completed

  Early Dronedarone Versus Usual Care to Improve Outcomes in Persons With Newly Diagnosed Atrial Fibrillation

  NCT05130268· Phase 4· Source

• Completed

  Optimizing Parameters of Low-Intensity Focused Ultrasound for Cortical Modulation in Stroke Patients

  NCT05016531· Source

• Completed

  Transcranial Direct Current Stimulation for Post-stroke Motor Recovery

  NCT03826030· Phase 2· Source

• Completed

  A Study of Zanubrutinib (BGB-3111) Versus Ibrutinib in Participants With Relapsed/Refractory Chronic Lymphocytic Leukemia

  NCT03734016· Phase 3· Source

• Completed

  Registry of Subjects With Drug Resistant Epilepsy and Treated With the VNS Therapy System.

  NCT03529045· Source

• Completed

  PF-06863135 As Single Agent And In Combination With Immunomodulatory Agents In Relapse/Refractory Multiple Myeloma

  NCT03269136· Phase 1· Source

• Completed

  Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile

  NCT01454297· Source